Pharma / Biotech

FDA Approves New Insulin Product

The FDA approved a new insulin product (Semglee, Mylan) indicated to improve glycemic control in adult and pediatric patients with type 1 diabetes mellitus and in adults with type 2 diabetes mellitus.

Source link

Related posts

* Demineralized Bone Matrix as a Carrier for Bone Morphogenetic Protein-2: Burst Release Combined with Long-Term Binding and Osteoinductive Activity Evaluated In Vitro and In Vivo.


Baloxavir treatment of ferrets infected with influenza A(H1N1)pdm09 virus reduces onward transmission.


BURN RELIEF (arsenic trioxide, atropa belladonna, lytta vesicatoria, causticum, picric acid, urtica urens, hypericum perforatum) spray [Natrural Creations, Inc.]


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy